United States · Funded startup

Who invested in Intellia Therapeutics

3 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$485Mraised across 3 rounds since 2014, from 3 sources

$15MSeries A$70MSeries B$400MDebt
Latest round
Debt, $400MSept 2026
Step-upi
5.7×
Investors
10
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201620182020202220242026
$15MSeries A$70MSeries B$400MDebt
First round
Series A, $15M
Nov 2014
Biggest round
$400M
Debt · Sept 2026
Usual gap between rounds
11 years
the median of 2

The rounds

  1. Sept 2026
    Debt$400M1 new3 returning

    Source recorded

  2. Sept 2015
    Series B$70M6 new2 returning

    From a historical funding recordSEC filing: $70M sold, first sale Aug 2015

  3. Nov 2014
    Series A$15M3 new

    From a historical funding record

Founders and team

From Intellia Therapeutics's own website and the SEC filings it signed: 8 on the team.

  • Bill ChaseIndependent Director
  • Brian GoffIndependent Director
  • John LeonardExecutive Officer, Directori
  • Jose RiveraExecutive Officeri
  • Nessan BerminghamExecutive Officer, Directori
  • Edward DulacTeam
  • Maria NataleTeam
  • Marika St. AmandTeam

On the board, as filediCarl GordonJean-Francois FormelaRachel Haurwitz

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

NovartisVC firm3rounds
Atlas VentureVC firm2rounds
OrbiMedPrivate equity2rounds
Foresite CapitalPrivate equity2rounds
FidelityVC firm1round
EcoR1 CapitalPrivate equity1round
Janus Capital GroupGrowth equity1round
Sectoral Asset ManagementPrivate equity1round
Caribou BiosciencesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Intellia Therapeutics

Who invested in Intellia Therapeutics?

Intellia Therapeutics's investors include Novartis, Atlas Venture, OrbiMed, Foresite Capital and Fidelity, and 5 more on record.

How much has Intellia Therapeutics raised?

Intellia Therapeutics has raised $485M across 3 rounds since 2014.

When did Intellia Therapeutics last raise?

Intellia Therapeutics's most recent round was a Debt of $400M in Sept 2026.

What was Intellia Therapeutics's biggest round?

Its most recent round, $400M in Sept 2026, is also its largest on record.

Who backed Intellia Therapeutics first?

Intellia Therapeutics's first round on record, in Nov 2014, was backed by Atlas Venture, Novartis and Caribou Biosciences.

What stage is Intellia Therapeutics at?

Intellia Therapeutics's latest named round is a Debt, in Sept 2026.

Where is Intellia Therapeutics based?

Intellia Therapeutics is based in the United States.

Companies like Intellia Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.